156 related articles for article (PubMed ID: 18820)
1. Bone marrow transplantation in the busulfin-treated rat. III. Relationship between myelosuppression and immunosuppression for conditioning bone marrow recipients.
Tutschka PJ; Santon GW
Transplantation; 1977 Jul; 24(1):52-62. PubMed ID: 18820
[No Abstract] [Full Text] [Related]
2. Bone marrow transplantation in the busulfan-treated rat. I. Effect of cyclophosphamide and rabbit antirat thymocyte serum as immunosuppression.
Tutschka PJ; Santos GW
Transplantation; 1975 Aug; 20(2):101-6. PubMed ID: 241143
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation in the busulfan-treated rat. II. Effect of cyclophosphamide and antithymic serum on the presensitized state.
Tutschka PJ; Santos GW
Transplantation; 1975 Aug; 20(2):116-22. PubMed ID: 809876
[TBL] [Abstract][Full Text] [Related]
4. Use of cyclosporin A (CsA) in a rat model of allogeneic marrow transplantation.
Tutschka PJ; Beschorner WE; Hess AD
Haematol Blood Transfus; 1980; 25():241-53. PubMed ID: 7021342
[No Abstract] [Full Text] [Related]
5. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
[TBL] [Abstract][Full Text] [Related]
6. Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation.
Uharek L; Gassmann W; Glass B; Steinmann J; Loeffler H; Mueller-Ruchholtz W
Blood; 1992 Mar; 79(6):1612-21. PubMed ID: 1547350
[TBL] [Abstract][Full Text] [Related]
7. Effect of antithymocyte globulin pretreatment on immunological reconstitution of lethally irradiated animals.
Allen EM; Gengozian N
Transplantation; 1975 Jun; 19(6):456-63. PubMed ID: 237349
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of the graft vs host reaction in rats by means of allogeneic antilymphocyte serum following bone marrow transplantation].
Jeannet M; Vaucher A; Gervasoni C
Schweiz Med Wochenschr; 1972 Nov; 102(44):1598-600. PubMed ID: 4405059
[No Abstract] [Full Text] [Related]
9. The role of donor passenger leukocytes in rat skin allograft rejection.
Kyger ER; Salyer KE
Transplantation; 1973 Dec; 16(6):537-43. PubMed ID: 4585381
[No Abstract] [Full Text] [Related]
10. Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow.
Müller-Ruchholtz W; Wottge HU; Müller-Hermelink HK
Transplant Proc; 1976 Dec; 8(4):537-41. PubMed ID: 11584
[No Abstract] [Full Text] [Related]
11. Studies of marrow transplantation in dogs.
Storb R; Weiden PL; Graham TC; Thomas ED
Transplant Proc; 1976 Dec; 8(4):545-9. PubMed ID: 11585
[No Abstract] [Full Text] [Related]
12. Induction of unresponsiveness to skin and heart allografts in mice by a synergistic treatment with procarbazine, antilymphocyte serum, and donor-type cells.
Floersheim GL
Transplantation; 1973 Feb; 15(2):195-205. PubMed ID: 4146168
[No Abstract] [Full Text] [Related]
13. Comparative effects of selected cytotoxic agents on transplanted hematopoietic cells.
Sensenbrenner LL; Owens AH; Zawatzsky LS; Elfenbein GJ
Transplantation; 1972 Sep; 14(3):347-51. PubMed ID: 4404694
[No Abstract] [Full Text] [Related]
14. Effect of graft inoculation with donor bone marrow cells on kidney allograft survival in antilymphocyte serum-treated rats.
Otsu I; Gottschalk R; Monaco AP
Transplant Proc; 1994 Oct; 26(5):3060. PubMed ID: 7940962
[No Abstract] [Full Text] [Related]
15. Experimental bone marrow transplantation.
Thierfelder S
Blut; 1975 Jan; 30(1):1-18. PubMed ID: 234260
[No Abstract] [Full Text] [Related]
16. Marrow transplantation in acute leukemia following busulfan and cyclophosphamide.
Tutschka PJ; Santos GW; Elfenbein GJ
Haematol Blood Transfus; 1980; 25():375-80. PubMed ID: 7021355
[No Abstract] [Full Text] [Related]
17. Bone marrow transplantation.
Santos GW
Adv Intern Med; 1979; 24():157-82. PubMed ID: 34319
[No Abstract] [Full Text] [Related]
18. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
[No Abstract] [Full Text] [Related]
19. Antilymphocytic antibodies and marrow transplantation. VI. Graft-versus-host tolerance in DLA-incompatible dogs after in vitro treatment of bone marrow with absorbed antithymocyte globulin.
Kolb HJ; Rieder I; Rodt H; Netzel B; Grosse-Wilde H; Scholz S; Schäffer E; Kolb H; Thierfelder S
Transplantation; 1979 Apr; 27(4):242-5. PubMed ID: 35870
[No Abstract] [Full Text] [Related]
20. Bone marrow transplantation: introduction.
Mathé G; Oldham R
Transplant Proc; 1974 Dec; 6(4):333-4. PubMed ID: 4155149
[No Abstract] [Full Text] [Related]
[Next] [New Search]
